secwatch / observer
8-K filed March 26, 2026, 7:59 PM ET ticker GCGJ CIK 0001765048
other material confidence high sentiment negative materiality 0.45

Guochun International (GCGJ) restates Sep 2025 financials; $8,250 error in G&A expenses

GUOCHUN INTERNATIONAL INC.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001765048-26-000002
form_type
8-K
ticker
GCGJ
cik
0001765048
company_name
GUOCHUN INTERNATIONAL INC.
filed_at
2026-03-26T23:59:59+00:00
discovered_at
2026-05-14T18:02:36.107477+00:00
generated_at
2026-05-15T08:52:03.946574+00:00
sec_items
["4.02"]
event_type
other_material
sentiment
negative
materiality_score
0.45
calibrated_materiality_score
0.45
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001765048-26-000002
json_url
https://secwatch.observer/filing/0001765048-26-000002.json
markdown_url
https://secwatch.observer/filing/0001765048-26-000002.md
text_url
https://secwatch.observer/filing/0001765048-26-000002.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1765048/000176504826000002/0001765048-26-000002-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1765048/000176504826000002/gcgj_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

d35770b5a5211547d3a2db5130e0483463f4b87e

GUOCHUN INTERNATIONAL INC. reported that prior financial statements should not be relied upon.

More specifically, the Company has restated its condensed financial statements as of and for the three and nine months ended September 30, 2025, to reverse the erroneous recording of the other

SEC 8-K Item 4.01/4.02 confidence 0.9 SEC evidence

Comparable filings

GWLL

Goldenwell Biotech to restate three quarterly reports over $9,840 legal fee timing errors

GOLDENWELL BIOTECH, INC. May 26, 2026, 8:17 PM ET other_material Items 4.02, 9.01

same fact type: auditor_change same SEC item: 4.02 same event type: other_material similar materiality

This filing

More specifically, the Company has restated its condensed financial statements as of and for the three and nine months ended September 30, 2025, to reverse the erroneous recording of the other

Comparable filing

the Company’s independent registered public accounting firm, Michael Gillsepie & Associates, PLLC (“Gillespie & Associates”), notified the Company that the Company did not follow US GAAP because an invoice dated September 23, 2025, from the Company’s legal counsel in the amount of $9,840 to the Company, which covered legal services rendered to the Company between May 21, 2024 and September 23, 2025, should have been recorded in the fiscal quarters when services were performed

Filing page SEC filing

BGFR

BestGofer restates Q1 FY2026; goodwill impairment of $78,754 increases net loss to $85,755

BestGofer Inc. May 19, 2026, 5:26 PM ET other_material Items 4.02, 2.06

same fact type: auditor_change same SEC item: 4.02 same event type: other_material similar materiality

This filing

More specifically, the Company has restated its condensed financial statements as of and for the three and nine months ended September 30, 2025, to reverse the erroneous recording of the other

Comparable filing

On May 5, 2026, the management of BestGofer, Inc. (the “Company”), in connection with the determination of a material non-cash impairment charge for the goodwill associated with the Company’s wholly-owned subsidiary, Liberty Home Inspection Services LLC (“LHIS”), concluded that the Company’s previously issued unaudited interim financial statements for the three months ended February 28, 2026, as filed with the Securities and Exchange Commission (the “SEC”) on April 22, 2026 in the Company’s Quarterly Report on Form 10-Q (SEC Accession No. 0001722556-26-000016) (the “Original Form 10-Q”), should no longer be relied upon.

Filing page SEC filing

GRBK

Green Brick restates 2023-2025 revenue/cost after audit committee finds accounting error

Green Brick Partners, Inc. April 29, 2026, 7:59 PM ET other_material Items 4.02

same fact type: auditor_change same SEC item: 4.02 same event type: other_material similar materiality

This filing

More specifically, the Company has restated its condensed financial statements as of and for the three and nine months ended September 30, 2025, to reverse the erroneous recording of the other

Comparable filing

On April 27, 2026, the Audit Committee (the “Committee”) of the Board of Directors of Green Brick Partners, Inc. (the “Company”), concluded that residential units revenue in prior periods had been incorrectly reported on a gross basis and excluded closing cost incentives offered to homebuyers, including interest-rate buy-downs, which had previously been included in cost of residential units.

Filing page SEC filing

LOB

Live Oak Bancshares to restate cash flow statements for FY2024 and Q1-Q2 2025; material weakness identified

Live Oak Bancshares, Inc. November 12, 2025, 6:59 PM ET other_material Items 4.02

same fact type: auditor_change same SEC item: 4.02 same event type: other_material similar materiality

This filing

More specifically, the Company has restated its condensed financial statements as of and for the three and nine months ended September 30, 2025, to reverse the erroneous recording of the other

Comparable filing

(the “Company”), in consultation with KPMG LLP (“KPMG”), the Company’s independent registered public accounting firm, concluded that the Company will amend its 2024 Annual Report on Form 10-K (the “FY2024 Form 10-K”) and the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2025 and June 30, 2025, respectively (collectively, the “Q1 and Q2 2025 Form 10-Qs”) to restate the Consolidated Financial Statements for each of the periods included in those filings in order to restate the Statements of Cash Flows and related notes as further described below. The FY 2024 Form 10-K and the Q1 and Q2 2025 Form 10-Qs are collectively referred to herein as the “Prior Filings.” In preparing the Company’s Consolidated Statements of Cash Flows for the quarter ended September 30, 2025, an error was identified in the classification of cash flows between operating and investing activiti

Filing page SEC filing

RITE

MineralRite restates financials, cuts asset carrying value from $432M to $246M

MINERALRITE Corp May 27, 2026, 4:02 PM ET other_material Items 4.02, 7.01, 8.01, 9.01

same fact type: auditor_change same SEC item: 4.02 same event type: other_material

This filing

More specifically, the Company has restated its condensed financial statements as of and for the three and nine months ended September 30, 2025, to reverse the erroneous recording of the other

Comparable filing

management determined that certain previously issued financial statements contained in the Company’s previously filed Annual Report on Form 10 for the fiscal year ended December 31, 2025, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, should no longer be relied upon.

Filing page SEC filing

NMTC

NeuroOne restates Q1 FY2026 results due to revenue recognition error; reaffirms FY2026 guidance

NEUROONE MEDICAL TECHNOLOGIES Corp May 22, 2026, 4:30 PM ET other_material Items 4.02, 7.01, 9.01

same fact type: auditor_change same SEC item: 4.02 same event type: other_material

This filing

More specifically, the Company has restated its condensed financial statements as of and for the three and nine months ended September 30, 2025, to reverse the erroneous recording of the other

Comparable filing

On May 21, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of NeuroOne Medical Technologies Corporation (the “Company”), after discussion with management, determined that the Company’s previously issued interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 12, 2026 (the “Previous Filing”), should no longer be relied upon and should be restated because of accounting errors relating to revenue recognition.

Filing page SEC filing

ZONE

CleanCore Solutions restates Q3 2026 financials; 70M Dogecoin transfer error

CleanCore Solutions, Inc. May 18, 2026, 4:30 PM ET other_material Items 4.02

same fact type: auditor_change same SEC item: 4.02 same event type: other_material

This filing

More specifically, the Company has restated its condensed financial statements as of and for the three and nine months ended September 30, 2025, to reverse the erroneous recording of the other

Comparable filing

concluded that the Company’s previously issued unaudited condensed consolidated financial statements included in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026, filed with the Securities and Exchange Commission (the “SEC”) on May 11, 2026 (the “Q3 2026 10-Q”), should no longer be relied upon and should be restated.

Filing page SEC filing

CGC

Canopy Growth restates FY2024-2025 financials due to warrant classification error; Q4/FY2026 results delayed to June 15

Canopy Growth Corp May 15, 2026, 5:06 PM ET other_material Items 4.02, 7.01, 9.01

same fact type: auditor_change same SEC item: 4.02 same event type: other_material

This filing

More specifically, the Company has restated its condensed financial statements as of and for the three and nine months ended September 30, 2025, to reverse the erroneous recording of the other

Comparable filing

the audit committee of the board of directors of the Company (the “Audit Committee”) was made aware of and, after discussion with senior management of the Company, concluded that the Company’s previously issued (i) audited consolidated financial statements for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2024 10-K”), (ii) audited consolidated financial statements for the fiscal year ended March 31, 2025, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2025 10-K”) and (iii) unaudited consolidated financial statements for the quarterly periods ended September 30, 2023, December 31, 2023, June 30, 2024, September 30, 2024, December 31, 2024, June 30, 2025, September 30, 2025, and December 31, 2025, included in the Company’s Quarterly Reports on Form 10-Q for such quarterly periods (collectively, the “Prior Financial Statements”), should no longer be relied upon

Filing page SEC filing

Source: SEC EDGAR
accession 0001765048-26-000002

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.